Nuveen Asset Management, LLC Immuno Gen, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $13.1 Million - $31.6 Million	-1,055,145 Reduced 33.95%	2,052,894 $60.9 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $6.56 Million - $9.25 Million	465,505 Added 17.62%	3,108,039 $49.3 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $2.07 Million - $11 Million	-550,980 Reduced 17.25%	2,642,534 $49.9 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $6.99 Million - $9.37 Million	1,905,334 Added 147.91%	3,193,514 $12.3 Million
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $2.89 Million - $4 Million	634,141 Added 96.96%	1,288,180 $6.39 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $1.36 Million - $1.97 Million	-304,512 Reduced 31.77%	654,039 $3.13 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $3.88 Million - $7.09 Million	-1,231,506 Reduced 56.23%	958,551 $4.31 Million
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $6.03 Million - $10.6 Million	1,415,091 Added 182.6%	2,190,057 $9.42 Million
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $261,520 - $412,927	-55,057 Reduced 6.63%	774,966 $4.75 Million
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $325,757 - $427,638	-64,892 Reduced 7.25%	830,023 $4.81 Million
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $91,806 - $136,361	-15,856 Reduced 1.74%	894,915 $5.9 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $324,083 - $525,015	49,859 Added 5.79%	910,771 $7.38 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $98,453 - $203,824	26,609 Added 3.19%	860,912 $5.55 Million
Q3 2020 Nov 16, 2020	SELL	$3.45 - $4.89 $466,509 - $661,225	-135,220 Reduced 13.95%	834,303 $3 Million
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $1.15 Million - $1.84 Million	-345,483 Reduced 26.27%	969,523 $4.46 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $1.4 Million - $4.5 Million	661,249 Added 101.15%	1,315,006 $4.48 Million
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $79,173 - $204,090	-35,188 Reduced 5.11%	653,757 $3.34 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $36,865 - $56,294	-16,606 Reduced 2.35%	688,945 $1.67 Million
Q2 2019 Aug 15, 2019	BUY	$1.8 - $3.3 $1.15 Million - $2.1 Million	636,449 Added 921.03%	705,551 $1.53 Million
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $61,515 - $80,542	7,153 Added 11.55%	69,102 $654,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $334,524 - $524,708	61,949	61,949 $474,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account